Doctor profile · Federal record
Dr. Linsey Ittyipe, FNP-C
Family Nurse Practitioner (CMS: Nurse Practitioner) · Bellaire, TX
- NPI 1558993733
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 10 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4710 Bellaire Blvd Ste 340
Bellaire, TX 774014530
(713) 218-0691 - Mailing address
-
911 Tennyson Dr
Pearland, TX 775843011
Credentials & registration
- NPI registered
- February 2020 — 6 yrs on file
- Year of graduation
- 2016 — 10 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Texas #AP144557
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1558993733. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
61,233
Distinct HCPCS
10
Medicare allowed
$1,577,986
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 29,820 | 70 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 11,940 | 173 | $23 | |
J1756 |
Injection, iron sucrose, 1 mg | 4,400 | 13 | $0 | |
J2182 |
Injection, mepolizumab, 1 mg | 3,900 | 12 | $29 | |
J3245 |
Injection, tildrakizumab, 1 mg | 3,200 | 18 | $138 | |
J2357 |
Injection, omalizumab, 5 mg | 3,195 | 17 | $38 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,324 | 17 | $33 | |
J0517 |
Injection, benralizumab, 1 mg | 1,230 | 20 | $162 | |
96372 |
Injection of drug or substance under skin or into muscle | 370 | 121 | $12 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 345 | 225 | $62 |
In context: peer comparison
Among 17 peers in Bellaire Family Nurse Practitioner, average services per provider: 1,467. This provider delivers 42× the peer median.Open Payments
Industry payments received
All-time total
$520
Transactions
22
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 9 | $190.84 | |
| Takeda Pharmaceuticals U.S.A., INC. | 4 | $104.57 | |
| Sanofi-Aventis U.S. LLC | 1 | $33.01 | |
| Lilly USA, LLC | 1 | $29.51 | |
| TerSera Therapeutics LLC | 1 | $26.61 | |
| Argenx US, INC. | 1 | $25.79 | |
| Amgen INC. | 1 | $25.03 | |
| Abbvie INC. | 1 | $23.53 | |
| Eisai INC. | 1 | $22.62 | |
| Adma BioManufacturing LLC | 1 | $20.29 | |
| Tg Therapeutics, INC. | 1 | $18.69 |
By nature of payment
Frequently asked questions
What is Dr. Linsey Ittyipe's medical specialty?
Dr. Linsey Ittyipe practices Family Nurse Practitioner in Bellaire, TX.
Where does Dr. Linsey Ittyipe practice?
Dr. Linsey Ittyipe practices at 4710 Bellaire Blvd Ste 340, Bellaire, TX 774014530. Office phone: 7132180691.
What is Dr. Linsey Ittyipe's NPI?
Dr. Linsey Ittyipe's National Provider Identifier (NPI) is 1558993733, issued by NPPES.
Does Dr. Linsey Ittyipe accept Medicare assignment?
Yes. Dr. Linsey Ittyipe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Linsey Ittyipe commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Injection, iron sucrose, 1 mg (HCPCS J1756). Source: CMS Medicare Physician & Other Practitioners file.